Non-invasive electromagnetic detection of prostate cancer: efficiency analysis

Non-invasive electromagnetic detection of prostate cancer: efficiency analysis

Introduction. Early diagnosis of cancer is one of the most important international strategies. Malignant and healthy tissues differ in the interaction with electromagnetic waves. Pilot studies show a potential perspective for non-invasive analysis of electromagnetic anisotropy in biological tissues....

Full description

Bibliographic Details
Main Authors:	M. E. Chaliy, E. V. Afanasyevskaya, A. S. Amirkhanyan, A. A. Strigunov, A. M. Kadysheva, E. V. Kolygina, A. S. Shurygina, A. S. Tivtikyan, A. V. Kadrev, V. K. Dzitiev, D. A. Okhobotov, N. I. Sorokin, A. A. Kamalov
Format:	Article
Language:	Russian
Published:	Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education 2023-04-01
Series:	Вестник урологии
Subjects:	prostate cancer tissue resonance interaction prostate-specific antigen
Online Access:	https://www.urovest.ru/jour/article/view/675

Similar Items

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

The Impact of prostate – Specific Antigen Density In Predicting Prostate Cancer
by: Abdul-Kareem Sh. Al-Khafaji, et al.
Published: (2019-11-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

BIOMARKERS FOR DIAGNOSING OF PROSTATE CANCER: THE PRESENT AND THE FUTURE
by: L. M. Rapoport, et al.
Published: (2018-05-01)

Consistency between Gleason score of prostate biopsy and radical prostatectomy: predictors of increased tumour grading
by: O. Yu. Nesterova, et al.
Published: (2024-09-01)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
by: Youngjun Boo, et al.
Published: (2023-07-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

Selection criteria for minimally invasive endoscopic treatment of urolithiasis depending on stone characteristics
by: N. I. Sorokin, et al.
Published: (2023-07-01)

Epidemiological Study of Patients with Prostate Cancer in South of Iraq
by: Manal Badi Salih Al-Tmemi
Published: (2019-07-01)

General anesthesia does not affect the serum complexed and free prostate specific antigen levels
by: E Doruk, et al.
Published: (2004-07-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Research of the best screen interval for middle aged and elderly Chinese males with baseline prostate specific antigen levels <2.0 ng/mL in prostate cancer screening
by: Yu Chen, et al.
Published: (2024-09-01)

Effect of Temperature and Humidity on Serum Prostate Specific Antigen Levels in Asymptomatic Male Population
by: Murat Tuğrul Eren, et al.
Published: (2016-12-01)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels
by: Nermina Obralic, et al.
Published: (2011-11-01)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
by: Chaoran Ma, et al.
Published: (2023-04-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01)

Effect of Antibiotic on Men with Raised Prostatic-Specific Antigen (4-10 ng/ml)
by: Abdulsattar J. Ali, et al.
Published: (2020-12-01)

Perception, Practice, and Attitude Toward Prostate-specific Antigen Test Among Sudanese Urologists
by: Mosab A.A Alzubier, et al.
Published: (2023-12-01)

Ascite-solid model of prostate cancer and its morphological characteristics
by: E. A. Plotnikova, et al.
Published: (2023-09-01)

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2024-01-01)

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
by: Matthew J. Roberts, et al.
Published: (2016-09-01)

Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
by: Kyo Chul Koo, et al.
Published: (2013-09-01)

Correlation of serum prostate-specific antigen with gleason's score/grade group in prostate cancers and their histopathological findings: A 4-year retrospective study at a tertiary care center
by: Ritu Sharma, et al.
Published: (2023-01-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01)

Synthesis and Preclinical Evaluation of Small-Molecule Prostate-Specific Membrane Antigen-Targeted Abiraterone Conjugate
by: Aleksei E. Machulkin, et al.
Published: (2022-12-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Age-specific Reference Range of Prostate-specific Antigen among Indian Men: A Retrospective Observational Study
by: Mamatha T. Shenoy, et al.
Published: (2021-01-01)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

The Effect of Ofloxacin on Prostate Specific Antigen Level in Men with High Antigen
by: SMR Rabbani
Published: (2022-07-01)